Search Results - "Fauceglia, P"

Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique by Mhawech-Fauceglia, P, Zhang, S, Terracciano, L, Sauter, G, Chadhuri, A, Herrmann, F R, Penetrante, R

“…Aims:  To determine prostate‐specific membrane antigen (PSMA) expression in normal tissues and in 3161 benign and malignant tumours and subsequently to define…”
Get full text

The source of APRIL up-regulation in human solid tumor lesions by Mhawech‐Fauceglia, P., Kaya, G., Sauter, G., McKee, T., Donze, O., Schwaller, J., Huard, B.

“…Abundant mRNA expression for a proliferation‐inducing ligand (APRIL) from tumor necrosis factor (TNF) family is observed in many solid tumors. Here, we…”
Get full text

Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis by Lin, Y G, Shen, J, Yoo, E, Liu, R, Yen, H-Y, Mehta, A, Rajaei, A, Yang, W, Mhawech-Fauceglia, P, DeMayo, F J, Lydon, J, Gill, P, Lee, A S

“…Rates of the most common gynecologic cancer, endometrioid adenocarcinoma (EAC), continue to rise, mirroring the global epidemic of obesity, a well-known EAC…”
Get full text

Intersection of the DNA repair pathways and immunogenome identifies PDL2 as a prognostic marker in ovarian epithelial cancer by Allen, A.J, Mhawech-Fauceglia, P, Matsuo, K, Pejovic, N, Krieg, A, Pejovic, T

Get full text

Discrepant cervical cytology and colposcopic directed biopsies: Clinical predictive factors by Ramzan, A, Meneses, T, Lin, Y, Fauceglia, P

Get full text

Expression of DNA repair proteins in endometrial cancer predicts disease outcome by Mhawech-Fauceglia, P, Liu, S, Pejovic, T

Get full text

Strategic cotargeting in epithelial ovarian cancer: FOXM1 by Garcia, J, Lawrenson, K, Mhawech-Fauceglia, P, Roman, L.D, Gayther, S.A

Get full text

Sperm protein 17 is a novel biomarker for low grade serous ovarian adenocarcinoma by Brunette, L.L, DaSilva, D, Mhawech-Fauceglia, P, Kast, W.M

Get full text

Response to letter regarding the paper entitled “Prognostic factors in stage II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium” by Mhawech-Fauceglia, P

Get full text

Nestin: A biomarker of aggressive uterine cancers by Hope, E.R, Mhawech-Fauceglia, P, Pejovic, T, Zahn, C.M, Conrads, T.P, Maxwell, G.L, Hamilton, C.A, Darcy, K.M, Syed, V

Get full text

Targeting Src in endometriosis-associated ovarian cancer by Manek, R, Pakzamir, E, Mhawech-Fauceglia, P, Pejovic, T, Sowter, H, Gayther, S A, Lawrenson, K

“…The SRC proto-oncogene is commonly overexpressed or activated during cancer development. Src family kinase inhibitors are approved for the treatment of certain…”
Get full text

Surrogates of progression-free survival in endometrial cancer patients: An evaluation of necrosis and other measures of tissue composition by Penick, E.R, Tian, C, Wang, G, Bateman, N.W, Mhawech-Fauceglia, P, Gist, G, Conrads, T.P, Hamilton, C.A, Maxwell, G.L, Darcy, K.M

Get full text

Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies by Mhawech-Fauceglia, P, Herrmann, F, Penetrante, R, Beck, A, Sait, S, Block, A M, Odunsi, K, Fisher, J, Balos, L, Cheney, R T

“…Aims:  To compare the sensitivity and specificity of the recently commercially available FLI‐1 monoclonal (FLI‐1m) antibody with the currently used antibodies…”
Get full text

Pair-Box (PAX8) protein-positive expression is associated with poor disease outcome in women with endometrial cancer by Mhawech-Fauceglia, P, Wang, D, Samrao, D, Godoy, H, Pejovic, T, Liu, S, Lele, S

“…Background: The Pax8 transcription factor genes have a role in cell differentiation and cell growth, and silencing of Pax8 in cell cultures results in cell…”
Get full text

Clinicopathologic factors predictive of concurrent endometrial carcinoma in women with a preoperative diagnosis of endometrial hyperplasia by Gualtieri, M.R, Mhawech-Fauceglia, P, Graham, K, Ciccone, M, Dancz, C, Ueda, Y, Roman, L.D, Matsuo, K

Get full text

FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer by Mhawech-Fauceglia, P., Cheney, R.T., Fischer, G., Beck, A., Herrmann, F.R.

“…This study is designed to evaluate the expression and prognostic value of FGFR3 protein expression in patients with pTa/pT1 tumours and to determine the…”
Get full text

Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas by Mhawech-Fauceglia, P, Allal, A, Odunsi, K, Andrews, C, Herrmann, F.R, Huard, B

“…Abstract A proliferation inducing ligand (APRIL) from the tumour necrosis family (TNF) promotes the natural development of solid tumours in pre-clinical…”
Get full text

Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease by SCHWALLER, J, WENT, P, MATTHES, T, DIRNHOFER, S, DONZE, O, MHAWECH-FAUCEELIA, P, MYIT, S, HUARD, B

Get full text

BRCAness profile of ovarian cancer predicts disease recurrence by Pejovic, T, Li, H, Syriac, S, Zhang, W, Mhawech-Fauceglia, P

Get full text

Prognostic factors in stages II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium by Mhawech-Fauceglia, P, Herrmann, R.F, Kesterson, J, Izevbaye, I, Lele, S, Odunsi, K

“…Abstract Aims To explore and to compare the outcome of patients diagnosed with stage II/III/IV and stage III/IV endometrioid adenocarcinoma (EAC) with their…”
Get full text